Clinical Trial Update: Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial of cediranib maleate in combination chemotherapy for advanced biliary cancers was terminated and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer
• Periampullary Cancer

Drugs mentioned

• Cediranib (Cediranib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Primary Cholangiocellular Carcinoma, Advanced Adult Primary Liver Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-03-29